SPA
vs
CLEO
SPA
CLEO
Over the past 12 months, SPA has significantly outperformed CLEO, delivering a return of +48% compared to the CLEO's 49% drop.
Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
Smart Verdict
AI-Powered
Let AI Decide.
SPA
CLEO
Valuation Comparison
| Company | Last Price | Intrinsic Value | DCF Value | Relative Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
Societe de Services de Participations, de Direction et d'Elaboration SA
XBRU:SPA
|
268
EUR
|
|||||
|
Sariguna Primatirta Tbk PT
IDX:CLEO
|
404
IDR
|
|||||
Compare the stock's valuation with its competitors.
Growth Comparison
Growth Over Time
SPA, CLEO
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
Societe de Services de Participations, de Direction et d'Elaboration SA
Revenue
|
|||||||||||
|
Sariguna Primatirta Tbk PT
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
SPA, CLEO
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
Societe de Services de Participations, de Direction et d'Elaboration SA
XBRU:SPA
|
|||||||||
|
Sariguna Primatirta Tbk PT
IDX:CLEO
|
|||||||||
Compare company's free cash flow with its competitors.
Gross Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Societe de Services de Participations, de Direction et d'Elaboration SA | ||||
|
Sariguna Primatirta Tbk PT | ||||
Operating Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Societe de Services de Participations, de Direction et d'Elaboration SA | ||||
|
Sariguna Primatirta Tbk PT | ||||
Net Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Societe de Services de Participations, de Direction et d'Elaboration SA | ||||
|
Sariguna Primatirta Tbk PT | ||||
FCF Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Societe de Services de Participations, de Direction et d'Elaboration SA | ||||
|
Sariguna Primatirta Tbk PT | ||||
ROE
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Societe de Services de Participations, de Direction et d'Elaboration SA | ||||
|
Sariguna Primatirta Tbk PT | ||||
ROA
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Societe de Services de Participations, de Direction et d'Elaboration SA | ||||
|
Sariguna Primatirta Tbk PT | ||||
ROIC
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Societe de Services de Participations, de Direction et d'Elaboration SA | ||||
|
Sariguna Primatirta Tbk PT | ||||
ROCE
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Societe de Services de Participations, de Direction et d'Elaboration SA | ||||
|
Sariguna Primatirta Tbk PT | ||||
Solvency Comparison
Compare company's equity waterfall with its competitors.
Stocks Performance
Stocks Performance
SPA, CLEO
Performance Gap
SPA, CLEO
Performance By Year
SPA, CLEO
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
| US |
P
|
Primo Brands Corp
NYSE:PRMB
|
|
| CN |
C
|
China Resources Beverage Holdings Co Ltd
HKEX:2460
|
|
| MY |
F
|
Fraser & Neave Holdings Bhd
KLSE:F&N
|
|
| ID |
|
Sariguna Primatirta Tbk PT
IDX:CLEO
|
|
| ID |
|
Akasha Wira International Tbk PT
IDX:ADES
|
|
| KR |
W
|
WooDeumGeeFarm Co Ltd
KOSDAQ:403490
|
|
| CA |
|
Beckett's Inc
OTC:BKTSF
|
|
| IN |
G
|
Galactico Corporate Services Ltd
BSE:542802
|
|
| ID |
|
Tri Banyan Tirta Tbk PT
IDX:ALTO
|
|
| US |
A
|
Accredited Solutions Inc
OTC:ASII
|